drugset / Trial / NCT01086150

Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy

NCT01086150

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to see if an investigational drug known as the lidocaine 5% patch is safe and effective in reducing the symptoms of diabetic neuropathy, to examine how topical lidocaine affects the nerve endings, and to determine whether treatment with the lidocaine patch can prevent the potential progression to chronic diabetic neuropathy pain in subjects who did not report pain at the start of the study.

Timeline

Start
2009-10
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 5 %